These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8301979)

  • 1. [Treatment of simultaneous episodes of angina and respiration disorders].
    Lazebnik LB; Lesnia EA; Tereshchenko SN
    Klin Med (Mosk); 1993; 71(5):27-9. PubMed ID: 8301979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Approaches to the personal antianginal therapy. Can we consider nitrosorbide as a drug of choice?].
    Zhiliaev EV; Glazunov AV; Koroba GS
    Klin Med (Mosk); 1994; 72(4):62-4. PubMed ID: 7990387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamic study of the aerosol form of nitrosorbide (isomak)].
    Orlov VA; Zamotaev IP; Venediktova MG; Zavolovskaia LI
    Sov Med; 1991; (2):52-4. PubMed ID: 2057842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine].
    Ellingsen O; Kjekshus J
    Tidsskr Nor Laegeforen; 1984 Mar; 104(9):657-60. PubMed ID: 6729795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effects of isosorbide dinitrate by intravenous infusion in subjects in hemodynamic equilibrium].
    Cappello C; Fusaro MT; Fontana PL; Gini M; Mattioli G
    Minerva Cardioangiol; 1988; 36(1-2):49-54. PubMed ID: 3386854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Yang NI
    Am J Cardiol; 2005 Jan; 95(1):84-7. PubMed ID: 15619396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin].
    Ol'binskaia LI; Sizova ZhM; Ushakova AV
    Ter Arkh; 1998; 70(5):69-72. PubMed ID: 9644750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of nifedipine in association with nitroderivatives and betablocking drugs (author's transl)].
    Aquaro G; Belli R; Rey L; Pavia M; Idone P
    G Ital Cardiol; 1980; 10(10):1340-8. PubMed ID: 7239080
    [No Abstract]   [Full Text] [Related]  

  • 12. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries.
    Bugiardini R; Borghi A; Pozzati A; Ottani F; Morgagni GL; Puddu P
    Am J Cardiol; 1993 Aug; 72(3):343-7. PubMed ID: 8342515
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of action of isosorbide dinitrate.
    Russell RO; Mantle JA; Rogers WJ; Rackley CE
    Chest; 1979 Jan; 75(1):2-4. PubMed ID: 105835
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment.
    Jensen G; Trautner F; Rasmussen S; Hesse B
    Eur J Clin Pharmacol; 1983; 24(2):169-72. PubMed ID: 6840163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antianginal effect of transdermal isosorbide dinitrate (multicenter study)].
    Kékes E
    Orv Hetil; 1994 Oct; 135(44):2421-3. PubMed ID: 7970662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the exercise test for determining the optimal dose of prolonged-action nitrates in patients with angina pectoris].
    Martsevich SIu; Vygodin VA; Metelitsa VI
    Ter Arkh; 1981; 53(12):22-6. PubMed ID: 7347239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of isosorbide dinitrate and nitroglycerin in patients with angina pectoris].
    Zikmund M; Mayer O; Cepelák V
    Vnitr Lek; 1984 Nov; 30(11):1060-5. PubMed ID: 6440352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pectanginose boring arrested by inhalation of isosorbide dinitrate (author's transl)].
    Bräuer R; Otto C
    Schweiz Rundsch Med Prax; 1979 Jan; 68(4):117-23. PubMed ID: 760114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.